Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

被引:3211
作者
Matsushita, Kunihiro [1 ]
van der Velde, Marije [2 ]
Astor, Brad C. [1 ]
Woodward, Mark [3 ]
Levey, Andrew S. [4 ]
de Jong, Paul E. [2 ]
Coresh, Josef [1 ]
Gansevoort, Ron T. [2 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA
[2] Univ Groningen, Dept Nephrol, Univ Med Ctr Groningen, Groningen, Netherlands
[3] Univ Sydney, George Inst, Sydney, NSW 2006, Australia
[4] Tufts Med Ctr, Div Nephrol, Boston, MA USA
关键词
CHRONIC KIDNEY-DISEASE; RISK-FACTOR; CYSTATIN-C; SERUM CREATININE; POOLED ANALYSIS; RENAL-DISEASE; OLDER; PREVALENCE; EQUATION; EVENTS;
D O I
10.1016/S0140-6736(10)60674-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Substantial controversy surrounds the use of estimated glomerular filtration rate (eGFR) and albuminuria to define chronic kidney disease and assign its stages. We undertook a meta-analysis to assess the independent and combined associations of eGFR and albuminuria with mortality. Methods In this collaborative meta-analysis of general population cohorts, we pooled standardised data for all-cause and cardiovascular mortality from studies containing at least 1000 participants and baseline information about eGFR and urine albumin concentrations. Cox proportional hazards models were used to estimate hazard ratios (HRs) for all-cause and cardiovascular mortality associated with eGFR and albuminuria, adjusted for potential confounders. Findings The analysis included 105 872 participants (730 577 person-years) from 14 studies with urine albumin-to-creatinine ratio (ACR) measurements and 1128 310 participants (4 732110 person-years) from seven studies with urine protein dipstick measurements. In studies with ACR measurements, risk of mortality was unrelated to eGFR between 75 mL/min/1.73 m(2) and 105 mL/min/1.73 m(2) and increased at lower eGFRs. Compared with eGFR 95 mL/min/1.73 m(2), adjusted HRs for all-cause mortality were 1.18 (95% CI 1.05-1.32) for eGFR 60 mL/min/1.73 m(2), 1.57 (1.39-1.78) for 45 mL/min/1.73 m(2), and 3.14 (2.39-4.13) for 15 mL/min/1. 73 m(2). ACR was associated with risk of mortality linearly on the log-log scale without threshold effects. Compared with ACR 0.6 mg/mmol, adjusted HRs for all-cause mortality were 1.20 (1.15-1.26) for ACR 1.1 mg/mmol, 1.63 (1.50-1.77) for 3.4 mg/mmol, and 2.22 (1.97-2.51) for 33.9 mg/mmol. eGFR and ACR were multiplicatively associated with risk of mortality without evidence of interaction. Similar findings were recorded for cardiovascular mortality and in studies with dipstick measurements. Interpretation eGFR less than 60 mi./min/1.73 m(2) and ACR 1.1 mg/mmol (10 mg/g) or more are independent predictors of mortality risk in the general population. This study provides quantitative data for use of both kidney measures for risk assessment and definition and staging of chronic kidney disease.
引用
收藏
页码:2073 / 2081
页数:9
相关论文
共 50 条
[11]   The Case for Using Albuminuria in Staging Chronic Kidney Disease [J].
Gansevoort, Ron T. ;
de Jong, Paul E. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (03) :465-468
[12]  
Genuth S, 2003, DIABETES CARE, V26, P3160
[13]   Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J].
Go, AS ;
Chertow, GM ;
Fan, DJ ;
McCulloch, CE ;
Hsu, CY .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1296-1305
[14]   Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421
[15]   Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals - The HUNT II study [J].
Hallan, Stein ;
Astor, Brad ;
Romundstad, Solfrid ;
Aasarod, Knut ;
Kvenild, Kurt ;
Coresh, Josef .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (22) :2490-2496
[16]   International comparison of the relationship of chronic kidney disease prevalence and ESRD risk [J].
Hallan, Stein I. ;
Coresh, Josef ;
Astor, Brad C. ;
Asberg, Arne ;
Powe, Neil R. ;
Romundstad, Solfrid ;
Hallan, Hans A. ;
Lydersen, Stian ;
Holmen, Jostein .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (08) :2275-2284
[17]   Relation Between Kidney Function, Proteinuria, and Adverse Outcomes [J].
Hemmelgarn, Brenda R. ;
Manns, Braden J. ;
Lloyd, Anita ;
James, Matthew T. ;
Klarenbach, Scott ;
Quinn, Robert R. ;
Wiebe, Natasha ;
Tonelli, Marcello .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (05) :423-429
[18]   Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population [J].
Hillege, HL ;
Fidler, V ;
Diercks, GFH ;
van Gilst, WH ;
de Zeeuw, D ;
van Veldhuisen, DJ ;
Gans, ROB ;
Janssen, WMT ;
Grobbee, DE ;
de Jong, PE .
CIRCULATION, 2002, 106 (14) :1777-1782
[19]   The reasons for geographic and racial differences in stroke study: Objectives and design [J].
Howard, VJ ;
Cushman, M ;
Pulley, L ;
Gomez, CR ;
Go, RC ;
Prineas, RJ ;
Graham, A ;
Moy, CS ;
Howard, G .
NEUROEPIDEMIOLOGY, 2005, 25 (03) :135-143
[20]   Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men [J].
Ingelsson, Erik ;
Sundstrom, Johan ;
Lind, Lars ;
Riserus, Ulf ;
Larsson, Anders ;
Basu, Samar ;
Arnlov, Johan .
EUROPEAN HEART JOURNAL, 2007, 28 (14) :1739-1745